GSK "CHAYKA-2", Saint Petersburg

Economic indicators

Net profit (RAS) of GSK CHAYKA-2 dropped in 2023 6.33 times to 3.00 thousand RUB from 19.00 thousand RUB over the same period in 2022, the company informed.

Revenue increased in the accounting period by 0.64% to 315.00 thousand RUB from 313.00 thousand RUB over 2022.

Net profit (RAS) of GSK CHAYKA-2 grew over 2022 4.75 times to 19.00 thousand RUB from 4.00 thousand RUB over 2021, the company informed.

Revenue remained in the accounting period at the same level and made up 313.00 thousand RUB compared to 312.00 thousand RUB 312.00 thousand RUB.

Net profit (RAS) of GSK CHAYKA-2 dropped in 2021 by 20.00% to 4.00 thousand RUB from 5.00 thousand RUB over the same period in 2020, the company informed.

Revenue increased in the accounting period by 2.63% to 312.00 thousand RUB from 304.00 thousand RUB over 2020.

Net profit (RAS) of GSK CHAYKA-2 grew over 2020 1.67 times to 5.00 thousand RUB from 3.00 thousand RUB over 2019, the company informed.

Revenue decreased in the accounting period by 3.49% to 304.00 thousand RUB from 315.00 thousand RUB in 2019.

Net profit (RAS) of GSK CHAYKA-2 over 2019 was the same as in 2018 reaching 3.00 thousand RUB, the company informed.

Revenue decreased in the accounting period by 0.94% to 315.00 thousand RUB from 318.00 thousand RUB in 2018.

Net profit (RAS) of GSK CHAYKA-2 grew over 2018 1.50 times to 3.00 thousand RUB from 2.00 thousand RUB over 2017, the company informed.

Revenue decreased in the accounting period by 1.24% to 318.00 thousand RUB from 322.00 thousand RUB in 2017; cost of goods sold decreased by 1.56% to 315.00 thousand RUB from 320.00 thousand RUB; sales profit went up 1.50 times to 3.00 thousand RUB from 2.00 thousand RUB.

Net profit (RAS) of GSK CHAYKA-2 dropped in 2017 3.00 times to 2.00 thousand RUB from 6.00 thousand RUB over the same period in 2016, the company informed.

Revenue increased in the accounting period by 35.29% to 322.00 thousand RUB from 238.00 thousand RUB over 2016; cost of goods sold grew by 37.93% to 320.00 thousand RUB from 232.00 thousand RUB; sales profit fell 3.00 times to 2.00 thousand RUB from 6.00 thousand RUB.

Net profit (RAS) of GSK CHAYKA-2 made up 6.57 thousand RUB over 2016 compared to net loss of 33.60 thousand RUB over 2015, the company informed.

Revenue increased in the accounting period by 26.76% to 238.27 thousand RUB from 187.97 thousand RUB over 2015; cost of goods sold grew by 4.57% to 231.70 thousand RUB from 221.57 thousand RUB.

Companies in the region

• NPO SEVER
• RICH-AVTOLAYN
• PKF KRISTALL
• MILA PLYUS
• AVANGARDSTROY